Diagnosis of thoracic SMARCA4-deficient undifferentiated tumor in cytology

Cancer Cytopathol. 2023 Aug;131(8):526-534. doi: 10.1002/cncy.22709. Epub 2023 Jun 6.

Abstract

Introduction: Although alterations in SMARCA4-deficient occur in non-small cell lung carcinoma (SD-NSCLC), thoracic SMARCA4-deficient undifferentiated tumor (TSDUT) is recognized as a distinct entity in the 2021 World Health Organization Classification of Thoracic Tumors because of unique morphologic, immunophenotypic and molecular features, and worse survival compared with SD-NSCLC. Cytologic diagnosis of TSDUT is clinically important because of its aggressive behavior and because it is often diagnosed by fine-needle aspiration because TSDUTs are usually unresectable at presentation. Here, we identify cytologic features that can be used for recognition of TSDUT and distinction from SD-NSCLC.

Materials and methods: Cytomorphologic features were investigated in cytology specimens from patients with TSDUT (n = 11) and compared with a control group of patients with SD-NSCLC (n = 20).

Results: The presence of classic rhabdoid morphology, at least focally, was entirely specific for TSDUT (n = 6, 55%) compared with SD-NSCLC (n = 0) in this study. TSDUT more frequently showed tumor necrosis (n = 11, 100% vs. n = 8, 40%; p = .001), dominant single-cell pattern on aspirate smears or touch preparation slides (n = 8 [of 9], 80% vs. n = 3, 15%; p = .010), nuclear molding (n = 5, 45% vs. n = 1, 5%; p = .013), and indistinct cell borders (n = 11, 100% vs. n = 5, 25%; P < .001) compared with SD-NSCLC, respectively.

Conclusions: Cytomorphologic features occurring more frequently in TSDUT include tumor necrosis, dominant single-cell pattern, nuclear molding indistinct cell borders, and focal rhabdoid cells. Presence of these features in a cytology specimen of an undifferentiated tumor, particularly in a patient with a thoracic mass, should raise suspicion for TSDUT and prompt appropriate ancillary workup.

Keywords: SMARCA4-deficient thoracic sarcomatoid tumor (SD-TST); cytopathology; non-small cell lung carcinoma (NSCLC); thoracic SMARCA4-deficient undifferentiated tumor (TSDUT); thoracic tumors.

MeSH terms

  • Biomarkers, Tumor
  • Carcinoma, Non-Small-Cell Lung* / diagnosis
  • Cytological Techniques
  • DNA Helicases
  • Humans
  • Lung Neoplasms* / diagnosis
  • Necrosis
  • Nuclear Proteins
  • Small Cell Lung Carcinoma*
  • Thoracic Neoplasms* / diagnosis
  • Thoracic Neoplasms* / pathology
  • Transcription Factors

Substances

  • Biomarkers, Tumor
  • SMARCA4 protein, human
  • DNA Helicases
  • Nuclear Proteins
  • Transcription Factors